Related Experiment Videos
New simplified molecular design for functional T cell receptor
T Brocker1, A Peter, A Traunecker
1Basel Institute for Immunology, Switzerland.
European Journal of Immunology
|July 1, 1993
Summary
Researchers created a novel single-chain T cell receptor (TcR) by fusing antibody recognition with T cell signaling. This engineered TcR enables T cells to target specific cells and activate immune responses, offering new possibilities for immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- T cell receptors (TcRs) are crucial for adaptive immunity, mediating target cell recognition and immune signaling.
- The TcR/CD3 complex orchestrates T cell activation upon antigen binding.
- Engineering T cells with novel specificities is a key goal in immunotherapy.
Purpose of the Study:
- To develop a chimeric single-chain T cell receptor (TcR) integrating antibody-based antigen recognition with TcR/CD3 signaling.
- To assess the functionality of this engineered TcR in mediating T cell responses.
Main Methods:
- Construction of a single-chain TcR by linking an antibody combining site to the CD3 zeta chain's signaling domains via a spacer.
- Expression of the chimeric TcR in T cell hybridomas (TcR- and TcR+).
- Evaluation of target cell recognition and lymphokine production.
Main Results:
- The chimeric single-chain TcR successfully integrated antibody recognition and TcR/CD3 signaling within one polypeptide.
- Expression of the engineered TcR in T cells enabled recognition of target cells.
- Functional replacement of the endogenous TcR/CD3 complex was demonstrated, leading to lymphokine production.
Conclusions:
- The developed single-chain TcR model provides a versatile platform for redirecting T cell specificity.
- This approach offers a novel strategy for generating T cells with engineered targeting capabilities for therapeutic applications.